Dennis Marcus, MD
Enriched profileMedical Director, Southeast Retina Center; Clinical Professor of Ophthalmology, Medical College of Georgia, Augusta University · Southeast Retina Center
Dennis Marcus is Medical Director, Southeast Retina Center; Clinical Professor of Ophthalmology, Medical College of Georgia, Augusta University at Southeast Retina Center. OpenAlex indexes 197 publications with 11,591 citations (h-index 44); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
Dennis M. Marcus, MD, is Medical Director, Southeast Retina Center. The public record shows 197 publications with 11,591 citations (h-index 44), centered on Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 15 companies, 1 NIH-funded awards (2003–2004).
- Top research focus: Retinal Diseases and Treatments
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 95.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
Sponsor: Heidelberg Engineering GmbH
- IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab
Sponsor: Southeast Retina Center, Georgia
- Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
Sponsor: Southeast Retina Center, Georgia
Industry payments
Updated 1 Sept 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20253 payments
- Ocular Therapeutix, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
84.2%Antineovascularisation agents82.7%Faricimab-svoa100%Part B, office-administered≥151 patientsCorticosteroid0.8%Prednisolone Acetate100%Part D≥155 patientsCancer & immunology
14.8%Complement Inhibitor12.1%Pegcetacoplan100%Part B, office-administered≥31 patientsVascular Endothelial Growth Factor Inhibitor2.7%Aflibercept73%Bevacizumab27%Part B, office-administered≥139 patientsMusculoskeletal
0.4%Cyclooxygenase Inhibitor0.4%Ketorolac Tromethamine100%Part D≥45 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 1 Sept 2026
1 NIH research award on record, funded 2003–2004 per NIH RePORTER. The latest:
- XANTHOPHYLL-MEDIATED RETINAL DRUG DELIVERY
University of South Carolina at Columbia
FY2005$108,313R03EY014842
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Most-cited works
by citation count (OpenAlex)- 01Ranibizumab for Diabetic Macular Edema1,604 citations2012
- 02
- 03Intravitreal Aflibercept for Diabetic Macular Edema808 citations2014
- 04
- 05Intravitreal Aflibercept for Diabetic Macular Edema616 citations2015
Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dennis-marcus-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/heidelbergengineeringus/p/C9zoQ_fMSZk
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/p/DW3nq42mtWb
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southeastretina.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southeastretina.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southeastretina.com ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
American Academy of Ophthalmology's Focal Points
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Protocol Chair
DRCR Retina Network Protocol AA (ultra-widefield imaging in diabetic retinopathy, NEI-sponsored multicenter trial)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southeastretina.com ↗ - Former Executive Committee member
NEI-sponsored DRCR Retina Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
- Outstanding Young Faculty Award
Medical College of Georgia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Secondary affiliations
appointments beyond the home institution- Director of the Retina Service and tenured Professor of Ophthalmology (Vice-Chairman)
Medical College of Georgia, 1994-2005 (past role; institution now listed as current clinical faculty affiliation per ASRS)
2005provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Ophthalmology training/fellowship (ophthalmic pathology/ocular oncology research fellowship, residency, vitreoretinal surgical fellowship)
Massachusetts Eye and Ear Infirmary, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southeastretina.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.regenxbio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore